FindTrial
Sign In

MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/ß-catenin signaling pathway by down-regulating LHX2

MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/ß-catenin signaling pathway by down-regulating LHX2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018889
Enrollment
Unknown
Registered
2018-10-15
Start date
2017-03-01
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Case series:Nil

Sponsors

the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
28 Years to 71 Years

Inclusion criteria

Inclusion criteria: Patients were enrolled into our study if their first diagnosis was NPC; they did not receive radiotherapy, chemotherapy or biotherapy prior to the surgery; they had no history of resection or metastatic disease.

Exclusion criteria

Exclusion criteria: Patients without complete clinical data and patients with other primary tumor.

Design outcomes

Primary

MeasureTime frame
mRNA expression;—

Contacts

Public ContactDao-Ke Yang

the First Affiliated Hospital of Zhengzhou University

yangdaokedr@163.com+86 15903650068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026